The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"SH3 Domains
".
FunFam 126: Cytoplasmic protein
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 29 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
27 |
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
O43639 (/IPI)
(17 more) |
SH3/SH2 adaptor activity GO:0005070
Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
|
23 |
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
(13 more) |
Cytoskeletal adaptor activity GO:0008093
The binding activity of a molecule that brings together a cytoskeletal protein and one or more other molecules, permitting them to function in a coordinated way.
|
23 |
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
(13 more) |
Receptor signaling complex adaptor activity GO:0030159
Functions to provide a physical support for the assembly of a multiprotein receptor signaling complex.
|
23 |
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
(13 more) |
Eukaryotic initiation factor eIF2 binding GO:0071074
Interacting selectively and non-covalently with eukaryotic initiation factor eIF2, a protein complex involved in the initiation of ribosome-mediated translation.
|
15 |
B2RZ33 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
(5 more) |
Protein kinase inhibitor activity GO:0004860
Stops, prevents or reduces the activity of a protein kinase, an enzyme which phosphorylates a protein.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
SH3/SH2 adaptor activity GO:0005070
Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
13 |
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
(3 more) |
Protein binding, bridging GO:0030674
The binding activity of a molecule that brings together two or more protein molecules, or a protein and another macromolecule or complex, through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way.
|
13 |
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
P16333 (/IC)
(3 more) |
Receptor tyrosine kinase binding GO:0030971
Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
|
13 |
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
P16333 (/IPI)
(3 more) |
Cadherin binding GO:0045296
Interacting selectively and non-covalently with cadherin, a type I membrane protein involved in cell adhesion.
|
13 |
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
P16333 (/HDA)
(3 more) |
Phosphotyrosine residue binding GO:0001784
Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
|
10 | O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) O43639 (/IPI) |
SH3/SH2 adaptor activity GO:0005070
Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
|
3 | Q24218 (/ISS) Q8IPW2 (/ISS) Q9VPU1 (/ISS) |
Insulin receptor binding GO:0005158
Interacting selectively and non-covalently with the insulin receptor.
|
3 | Q24218 (/IPI) Q8IPW2 (/IPI) Q9VPU1 (/IPI) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
3 | Q24218 (/IPI) Q8IPW2 (/IPI) Q9VPU1 (/IPI) |
Cell adhesion molecule binding GO:0050839
Interacting selectively and non-covalently with a cell adhesion molecule.
|
3 | Q24218 (/IPI) Q8IPW2 (/IPI) Q9VPU1 (/IPI) |
Phosphotyrosine residue binding GO:0001784
Interacting selectively and non-covalently with a phosphorylated tyrosine residue within a protein.
|
1 | O55033 (/ISO) |
Protein kinase inhibitor activity GO:0004860
Stops, prevents or reduces the activity of a protein kinase, an enzyme which phosphorylates a protein.
|
1 | Q99M51 (/ISO) |
Protein kinase inhibitor activity GO:0004860
Stops, prevents or reduces the activity of a protein kinase, an enzyme which phosphorylates a protein.
|
1 | Q99M51 (/ISS) |
SH3/SH2 adaptor activity GO:0005070
Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
|
1 | Q9VPU1 (/IPI) |
SH3/SH2 adaptor activity GO:0005070
Interacting selectively and non-covalently and simultaneously with one or more signal transduction molecules, usually acting as a scaffold to bring these molecules into close proximity either using their own SH2/SH3 domains (e.g. Grb2) or those of their target molecules (e.g. SAM68).
|
1 | Q99M51 (/ISO) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | Q99M51 (/ISO) |
Kinase binding GO:0019900
Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
|
1 | Q9VPU1 (/IPI) |
Protein domain specific binding GO:0019904
Interacting selectively and non-covalently with a specific domain of a protein.
|
1 | Q99M51 (/IPI) |
Receptor tyrosine kinase binding GO:0030971
Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
|
1 | Q99M51 (/ISO) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | O55033 (/IPI) |
Ephrin receptor binding GO:0046875
Interacting selectively and non-covalently with an ephrin receptor.
|
1 | Q99M51 (/IPI) |
Eukaryotic initiation factor eIF2 binding GO:0071074
Interacting selectively and non-covalently with eukaryotic initiation factor eIF2, a protein complex involved in the initiation of ribosome-mediated translation.
|
1 | Q99M51 (/ISO) |
Scaffold protein binding GO:0097110
Interacting selectively and non-covalently with a scaffold protein. Scaffold proteins are crucial regulators of many key signaling pathways. Although not strictly defined in function, they are known to interact and/or bind with multiple members of a signaling pathway, tethering them into complexes.
|
1 | O55033 (/IPI) |
There are 65 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Signal complex assembly GO:0007172
The aggregation, arrangement and bonding together of a set of components to form a complex capable of relaying a signal within a cell.
|
23 |
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
(13 more) |
Positive regulation of actin filament polymerization GO:0030838
Any process that activates or increases the frequency, rate or extent of actin polymerization.
|
23 |
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
(13 more) |
Negative regulation of peptidyl-serine phosphorylation GO:0033137
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
23 |
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
(13 more) |
Positive regulation of T cell proliferation GO:0042102
Any process that activates or increases the rate or extent of T cell proliferation.
|
23 |
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
O43639 (/IMP)
(13 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
23 |
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
(13 more) |
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
23 |
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
(13 more) |
Negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation GO:1903912
Any process that stops, prevents or reduces the frequency, rate or extent of endoplasmic reticulum stress-induced eiF2alpha phosphorylation.
|
23 |
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
(13 more) |
Positive regulation of translation in response to endoplasmic reticulum stress GO:0036493
Any process that activates, or increases the frequency, rate or extent of translation as a result of endoplasmic reticulum stress.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Fc-gamma receptor signaling pathway involved in phagocytosis GO:0038096
An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes.
|
13 |
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
(3 more) |
T cell activation GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
13 |
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
(3 more) |
Negative regulation of insulin receptor signaling pathway GO:0046627
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
|
13 |
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
P16333 (/IMP)
(3 more) |
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
|
13 |
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
(3 more) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Peptidyl-serine dephosphorylation GO:0070262
The removal of phosphoric residues from peptidyl-O-phospho-L-serine to form peptidyl-serine.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902237
Any process that activates or increases the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Positive regulation of cap-dependent translational initiation GO:1903676
Any process that activates or increases the frequency, rate or extent of cap-dependent translational initiation.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Positive regulation of cap-independent translational initiation GO:1903679
Any process that activates or increases the frequency, rate or extent of cap-independent translational initiation.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Negative regulation of PERK-mediated unfolded protein response GO:1903898
Any process that stops, prevents or reduces the frequency, rate or extent of the PERK-mediated unfolded protein response.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress GO:1990441
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
10 | O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
10 | O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) |
Regulation of epidermal growth factor-activated receptor activity GO:0007176
Any process that modulates the frequency, rate or extent of EGF-activated receptor activity.
|
10 | O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
10 | O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) |
T cell activation GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
10 | O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) O43639 (/NAS) |
Ephrin receptor signaling pathway GO:0048013
The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
|
10 | O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) O43639 (/TAS) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
3 | Q24218 (/IGI) Q8IPW2 (/IGI) Q9VPU1 (/IGI) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
3 | Q24218 (/IMP) Q8IPW2 (/IMP) Q9VPU1 (/IMP) |
Myoblast fusion GO:0007520
A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
3 | Q24218 (/IGI) Q8IPW2 (/IGI) Q9VPU1 (/IGI) |
Actin filament organization GO:0007015
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.
|
2 | O55033 (/IMP) Q99M51 (/IMP) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
2 | O55033 (/IMP) Q99M51 (/IMP) |
Lamellipodium assembly GO:0030032
Formation of a lamellipodium, a thin sheetlike extension of the surface of a migrating cell.
|
2 | O55033 (/IMP) Q99M51 (/IMP) |
Positive regulation of actin filament polymerization GO:0030838
Any process that activates or increases the frequency, rate or extent of actin polymerization.
|
2 | O55033 (/ISO) Q99M51 (/ISO) |
Negative regulation of peptidyl-serine phosphorylation GO:0033137
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | O55033 (/ISO) Q99M51 (/ISO) |
Positive regulation of translation in response to endoplasmic reticulum stress GO:0036493
Any process that activates, or increases the frequency, rate or extent of translation as a result of endoplasmic reticulum stress.
|
2 | O55033 (/IGI) Q99M51 (/IGI) |
Positive regulation of T cell proliferation GO:0042102
Any process that activates or increases the rate or extent of T cell proliferation.
|
2 | O55033 (/ISO) Q99M51 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | O55033 (/ISO) Q99M51 (/ISO) |
Positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902237
Any process that activates or increases the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
2 | O55033 (/IGI) Q99M51 (/IGI) |
Negative regulation of PERK-mediated unfolded protein response GO:1903898
Any process that stops, prevents or reduces the frequency, rate or extent of the PERK-mediated unfolded protein response.
|
2 | O55033 (/IGI) Q99M51 (/IGI) |
Negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation GO:1903912
Any process that stops, prevents or reduces the frequency, rate or extent of endoplasmic reticulum stress-induced eiF2alpha phosphorylation.
|
2 | O55033 (/IGI) Q99M51 (/IGI) |
Negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation GO:1903912
Any process that stops, prevents or reduces the frequency, rate or extent of endoplasmic reticulum stress-induced eiF2alpha phosphorylation.
|
2 | O55033 (/ISO) Q99M51 (/ISO) |
Negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress GO:1990441
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
|
2 | O55033 (/IGI) Q99M51 (/IGI) |
Immunological synapse formation GO:0001771
The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
|
1 | D4A3M8 (/IGI) |
Immunological synapse formation GO:0001771
The formation of an area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and target cell, which facilitates activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
|
1 | O55033 (/ISO) |
Substrate-dependent cell migration, cell extension GO:0006930
The formation of a cell surface protrusion, such as a lamellipodium or filopodium, at the leading edge of a migrating cell.
|
1 | Q99M51 (/IGI) |
Positive regulation of neuron projection development GO:0010976
Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
1 | Q99M51 (/IMP) |
Regulation of cell migration GO:0030334
Any process that modulates the frequency, rate or extent of cell migration.
|
1 | Q99M51 (/IGI) |
Positive regulation of actin filament polymerization GO:0030838
Any process that activates or increases the frequency, rate or extent of actin polymerization.
|
1 | Q99M51 (/IGI) |
Positive regulation of translation in response to endoplasmic reticulum stress GO:0036493
Any process that activates, or increases the frequency, rate or extent of translation as a result of endoplasmic reticulum stress.
|
1 | Q99M51 (/ISO) |
T cell activation GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
1 | Q99M51 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q99M51 (/ISS) |
Negative regulation of insulin receptor signaling pathway GO:0046627
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
|
1 | Q9VPU1 (/IGI) |
Negative regulation of insulin receptor signaling pathway GO:0046627
Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
|
1 | Q99M51 (/ISO) |
Ephrin receptor signaling pathway GO:0048013
The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
|
1 | O55033 (/IDA) |
Ephrin receptor signaling pathway GO:0048013
The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin.
|
1 | Q99M51 (/IMP) |
Response to other organism GO:0051707
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from another living organism.
|
1 | Q99M51 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | Q99M51 (/ISO) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | Q99M51 (/ISS) |
Dendritic spine development GO:0060996
The process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
|
1 | D4A3M8 (/IGI) |
Dendritic spine development GO:0060996
The process whose specific outcome is the progression of the dendritic spine over time, from its formation to the mature structure. A dendritic spine is a protrusion from a dendrite and a specialized subcellular compartment involved in synaptic transmission.
|
1 | O55033 (/ISO) |
Peptidyl-serine dephosphorylation GO:0070262
The removal of phosphoric residues from peptidyl-O-phospho-L-serine to form peptidyl-serine.
|
1 | Q99M51 (/ISO) |
Positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902237
Any process that activates or increases the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
1 | Q99M51 (/ISO) |
Positive regulation of cap-dependent translational initiation GO:1903676
Any process that activates or increases the frequency, rate or extent of cap-dependent translational initiation.
|
1 | Q99M51 (/ISO) |
Positive regulation of cap-independent translational initiation GO:1903679
Any process that activates or increases the frequency, rate or extent of cap-independent translational initiation.
|
1 | Q99M51 (/ISO) |
Negative regulation of PERK-mediated unfolded protein response GO:1903898
Any process that stops, prevents or reduces the frequency, rate or extent of the PERK-mediated unfolded protein response.
|
1 | Q99M51 (/ISO) |
Negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress GO:1990441
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of an endoplasmic reticulum stress.
|
1 | Q99M51 (/ISO) |
There are 23 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
25 |
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
O43639 (/TAS)
(15 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
23 |
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
(13 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
23 |
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
O43639 (/NAS)
(13 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
23 |
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
O43639 (/IDA)
(13 more) |
Protein phosphatase type 1 complex GO:0000164
A protein complex that possesses magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) activity, and consists of a catalytic subunit and one or more regulatory subunits that dictates the phosphatase's substrate specificity, function, and activity.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
13 |
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
(3 more) |
Ribosome GO:0005840
An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.
|
13 |
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
P16333 (/IDA)
(3 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
13 |
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
P16333 (/TAS)
(3 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | O55033 (/ISO) Q99M51 (/ISO) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | O55033 (/ISO) Q99M51 (/ISO) |
Vesicle membrane GO:0012506
The lipid bilayer surrounding any membrane-bounded vesicle in the cell.
|
2 | O55033 (/IDA) Q99M51 (/IDA) |
Protein phosphatase type 1 complex GO:0000164
A protein complex that possesses magnesium-dependent protein serine/threonine phosphatase (AMD phosphatase) activity, and consists of a catalytic subunit and one or more regulatory subunits that dictates the phosphatase's substrate specificity, function, and activity.
|
1 | Q99M51 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | Q9VPU1 (/NAS) |
Ribosome GO:0005840
An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins.
|
1 | Q99M51 (/ISO) |
Cell-cell junction GO:0005911
A cell junction that forms a connection between two or more cells in a multicellular organism; excludes direct cytoplasmic junctions such as ring canals.
|
1 | Q99M51 (/IDA) |
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | D4A3M8 (/IDA) |
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | O55033 (/ISO) |
Nuclear body GO:0016604
Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins.
|
1 | Q9VPU1 (/IDA) |
Clathrin-coated vesicle GO:0030136
A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes.
|
1 | Q9VPU1 (/IDA) |
Male germline ring canal GO:0035323
An intercellular bridge that connects the germline cells of a male cyst.
|
1 | Q9VPU1 (/IDA) |
Synapse GO:0045202
The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
|
1 | D4A3M8 (/IDA) |
Synapse GO:0045202
The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
|
1 | O55033 (/ISO) |
Cell periphery GO:0071944
The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures.
|
1 | Q9VPU1 (/IDA) |